Speakers

Karen Moniz

Technical Director • ICCBBA

Karen Moniz, MHA, MT(ASCP)SBB, has been the Technical Director at ICCBBA, Inc, since 2020.  She is responsible for leading the technical development of the ISBT 128 Standard to meet the changing traceability, labeling, and coding needs for medical products of human origin (MPHO).  She studied medical technology at the University of Kentucky, specialized in immunohematology at Johns Hopkins Hospital, and studied healthcare administration at George Washington University.   Karen has decades of management experience in the management of blood donor centers, transfusion services, and biomedical information technology.  She was an early advocate for the implementation of the ISBT 128 Standard and remains enthusiastic about the future of the Standard to contribute to MPHO traceability, biovigilance, and electronic data transfer in addition to supporting ongoing harmonization of terminology in all sectors of medical products of human origin.

Also Speaking

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Carl H. June

Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania

Hanna Lesch

Chief Technology Officer • Exothera

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.